Corcept Therapeutics Incorporated CORT was a big mover last session, as the company saw its shares rise more than 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading within a volatile range of $15.77–$18.20 in the past one-month time frame, showed a sharp increase yesterday.
The upside was driven following the news that shares will be included in the S&P SmallCap 600 index.
The company has not seen any estimate revisions over the past one month, while the Zacks Consensus Estimate for the current quarter also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Corcept Therapeutics currently has a Zacks Rank #2 (Buy), while its Earnings ESP is 0.00%.
Corcept Therapeutics Incorporated Price
Corcept Therapeutics Incorporated Price | Corcept Therapeutics Incorporated Quote
Investors interested in the Medical – Drugs industry may consider Sucampo Pharmaceuticals, Inc. SCMP, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is CORT going up? Or down? Predict to see what others think: Up or Down
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment